Back to All Events

OBIO® Executive Exchange Series: Due Diligence for Deal Making – Perspectives from Both Sides of the Table with Ela Borenstein and Ihor Boszko

March 22nd, 2016 8:30-10:00AM OBIO invites you to join us for this exceptional members-only opportunity to learn from Ela Borenstein, Managing Partner, BDC Capital Healthcare Venture Fund and Ihor Boszko, Vice President, Business Development, Xagenic on how to prepare for the due diligence process to successfully close your financing! BDC Capital invested in Xagenic’s Series B round in 2015 to advance their X1TM platform and enzyme-free approach to molecular diagnostics.  

In person over breakfast and by webinar, Ela and Ihor will share their perspectives on best practices to help you understand: 

  • How to create a data room and elements of a data room,
  • What investors look for and what you need to have ready to share, and
  • Common mistakes and tips.

Join us and ask your questions!  

Ela Borenstein is Managing Partner in the Healthcare Fund. She joined BDC Venture Capital in 2007 and has over 20 years of management, entrepreneurial and consulting experience in the biopharmaceutical industry.

Ihor Boszko has more than a decade of experience developing, partnering and commercializing innovative technologies in the IVD industry. He joined Xagenic pre-Series A  in February 2011 to help build a leading-edge diagnostics company based on a promising detection technology.